The experience of the repeated administration of vitamin K for the prevention of hemorrhagic syndrome in premature infants
https://doi.org/10.18821/0234-5730-2016-61-3-150-153
Abstract
The purpose of this study is the investigation of the effectiveness of the repeated administration of vitamin K1 to preterm infants. 88 preterm infants were administered vitamin K1 in first hours of life at a dose of 1 mg intramuscularly, then repeatedly at 7th, 14th, 21th day after birth. Infants in the control group received vitamin K1 in a dose of 1 mg once at birth. The effectiveness of repeated administration of vitamin K1 was evaluated by the results of clinical, laboratory and instrumental data on the 21th day of life. The results showed that repeated administration of vitamin K1 reduces the length of stay of children in the ICU (15 ± 5.3 days in the study group, 18 ± 6 days in the control group), decreases of activated partial thromboplastin time as compared to the control group (53 to 29; p< 0.005), increases of prothrombin index (from 59.6 ± 7.2% to 86.7 ± 5%; p< 0.005), decreases of the number of children with retinopathy (6.5 ± 3.6% in the study group and 23.8 ± 6.6%; in the control (p< 0.05).
About the Authors
N. S. BozhbanbayevaKazakhstan
Almaty, 050000
E. M. Satbaeva
Kazakhstan
Satbaeva Elmira, MD, PhD, Head of the Department of Pharmacology
Almaty, 050000
A. M. Seytalieva
Kazakhstan
Almaty, 050000
G. B. Altynbayeva
Kazakhstan
Almaty, 050000
I. E. Suleimenova
Kazakhstan
Almaty, 050000
G. M. Pichkhadze
Kazakhstan
Almaty, 050000
References
1. Shabalov N.P. Neonatology. 5th ed. Moscow: MEDpress-inform; 2009. (in Russian)
2. Lobanov A.I., Lobanova O.G. Hemorrhagic disease of newborns with late debut. Current Pediatrics. Russian journal (Voprosy Sovremennoi Pediatrii). 2011; 1: 167–71 (in Russian).
3. Centers for Disease Control and Prevention (CDC). Notes from the field: late vitamin K deficiency bleeding in infants whose parents declined vitamin K prophylaxis – Tennessee, 2013. MMWR Morb. Mortal. Wkly. Rep.2013; 62(45): 901–2.
4. Wariyar U., Hilton S., Pagan J., Tin W., Hey E. Six years experience of prophylactic oral vitamin K. Arch. Dis. Child Fetal Neonatal. Ed. 2000; 82(1): F64–8.
5. Darlow B.A., Phillips A.A., Dickson N.P. New Zealand surveillance of neonatal vitamin K deficiency bleeding (VKDB): 1998–2008. J. Paediatr. Child. Health. 2011; 47(7): 460–4. doi: 10.1111/j.1440-1754.2010.01995.x.
6. Krasteleva I.M., Shishko G.A., Sevruk O.V., Timoshina L.A. Problems of treatment of hemorrhagic disease in newborn. Medical news. Russian journal (Meditsinskie novosti). 2014; 9: 60–2. (in Russian)
7. Narogan M.V., Karpova A.L., Stroeva L.E. Vitamin K deficient hemorrhagic syndrome in newborns and young infants. Neonatology: news, opinions, training. Russian journal (Neonatologiya: novosti, mneniya, obuchenie). 2015; 3: 74–82. (in Russian)
8. Ozdemir MA, Karakukcu M, Per H, Unal E, Gumus H, Patiroglu T. Late-type vitamin K deficiency bleeding: experience from 120 patients. Childs Nerv. Syst. 2012; 28(2): 247–51.
9. Takahashi D, Shirahata A, Itoh S, Takahashi Y, Nishiguchi T, Matsuda Y. Vitamin K prophylaxis and late vitamin K deficiency bleeding in infants: fifth nationwide survey in Japan. Pediatr. Int.2011; 53(6): 897–901.
10. Puckett R.M., Offringa M. Prophylactic vitamin K for vitamin K deficiency bleeding in neonates. Cochrane Database Syst. Rev. 2000; (4): CD002776. DOI: 10.1002/14651858.CD002776.
Review
For citations:
Bozhbanbayeva N.S., Satbaeva E.M., Seytalieva A.M., Altynbayeva G.B., Suleimenova I.E., Pichkhadze G.M. The experience of the repeated administration of vitamin K for the prevention of hemorrhagic syndrome in premature infants. Russian journal of hematology and transfusiology. 2016;61(3):150-153. (In Russ.) https://doi.org/10.18821/0234-5730-2016-61-3-150-153